Location History:
- Allston, MA (US) (2016)
- Cambridge, MA (US) (2015 - 2022)
- Belmont, MA (US) (2023)
- Medford, MA (US) (2017 - 2024)
Company Filing History:
16 out of 444 
4 out of 4 Years Active: 2015-2025
Title: The Innovative Contributions of Alfica Sehgal in Pharmaceutical Science
Introduction: Alfica Sehgal, based in Medford, MA, has established himself as a notable inventor with a robust portfolio comprising 19 patents. His contributions to pharmaceutical science reflect a commitment to addressing complex medical conditions through innovative chemistries and molecular biology techniques.
Latest Patents: Among his latest innovations, Alfica developed "Phenothiazine derivatives and uses thereof," which includes compounds, processes for their preparation, and pharmaceutical compositions aimed at treating various diseases, particularly ribosomal disorders such as Diamond Blackfan anemia (DBA). Additionally, he holds a patent for "SERPINA1 iRNA compositions and methods of use thereof," focusing on RNAi agents that target the Serpina1 gene. This invention offers new methods for treating liver disorders associated with Serpina1 expression, showcasing his ability to merge cutting-edge research with practical healthcare applications.
Career Highlights: Alfica has contributed to the pharmaceutical industry through his work at notable companies such as Alnylam Pharmaceuticals and Camp4 Therapeutics Corporation. His experience in these environments has allowed him to hone his skills in drug development and innovative therapeutic solutions.
Collaborations: Throughout his career, Alfica has collaborated with esteemed colleagues like Brian R. Bettencourt and Martin A. Maier. These partnerships have enhanced his research output and fostered a collaborative approach to tackling challenging medical problems.
Conclusion: Alfica Sehgal's innovative patents and collaborations within the pharmaceutical industry highlight his significant role as an inventor. His work not only showcases his technical expertise but also reflects a dedication to improving patient outcomes through targeted and novel therapies. As he continues to develop groundbreaking solutions, his contributions will likely remain influential in the realm of medical science.